<PAGE> 1
<TABLE>
------ U.S. SECURITIES AND EXCHANGE COMMISSION ------------------------------
FORM 4 WASHINGTON, D.C. 20549 OMB APPROVAL
------ ------------------------------
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287
[ ] Check box if no Expires: December 31, 2001
longer subject to Filed pursuant to Section 16(a) of the Securities Estimated average burden
Section 16. Form 4 Exchange Act of 1934, Section 17(a) of the hours per response.........0.5
or Form 5 obligations Public Utility Holding Company Act of 1935 ------------------------------
may continue. See or Section 30(f) of the Investment Company
Instruction 1(b). Act of 1940
(Print or Type Responses)
<S> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person to
Vulcan Ventures, Inc. Rosetta Inpharmatics, Inc. (RSTA) Issuer (Check all applicable)
--------------------------------------------- ---------------------------------------------- Director X 10% Owner
(Last) (First) (Middle) 3. IRS or Social Security 4. Statement for ---- ---
110 110th Avenue NE, Suite 550 Number of Reporting Month/Year Officer (give Other (Specify
--------------------------------------------- Person (Voluntary) August 2000 ---- title --- below)
(Street) ------------------ below)
Bellevue WA 98004 5. If Amendment,
--------------------------------------------- -------------------------- Date of Original --------------------------------
(City) (State) (Zip) (Month/Year)
7. Individual or Joint/Group Filing
------------------ (Check applicable line)
X Form filed by one
---- Reporting Person
Form filed by more than
---- one Reporting Person
------------------------------------------------------------------------------------------------------------------------------------
TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Transac- 4. Securities Acquired (A) 5. Amount of Se- 6. Owner- 7. Nature
(Instr. 3) action tion or Disposed of (D) curities Benefi- ship of In-
Date Code (Instr. 3, 4 and 5) cially Owned at Form: direct
(Instr. 8) End of Month Direct Benefi-
(Month/ (Instr. 3 and 4) (D) or cial
Day/ --------------------------------------- Indirect Owner-
Year) Code V Amount (A) or Price (I) ship
(D) (Instr. 4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 C 1,000,000 A I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 C 740,741 A I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 C 1,602,564 A I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 X 223,125 A(1) $0.45 I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 J 7,172 D $14.00 I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 08/08/00 P 250,000 A $14.00 3,809,258 I Vulcan Ventures
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
*If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 1474 (3-99)
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF
INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND
UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
</TABLE>
<PAGE> 2
<TABLE>
<CAPTION>
FORM 4 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<S> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date Exer- 7. Title and Amount 8. Price
Security sion or action action Derivative cisable and of Underlying of
(Instr. 3) Exercise Date Code Securities Ac- Expiration Securities Deriv-
Price of (Month/ (Instr. 8) quired (A) or Date (Instr. 3 and 4) ative
Deriv- Day/ Disposed of (D) (Month/Day/ Secur-
ative Year) (Instr. 3, 4, Year) ity
Security and 5) (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
Code V (A) (D) Date Expira- Title Amount or
Exer- tion Number of
cisable Date Shares
------------------------------------------------------------------------------------------------------------------------------------
Series A Preferred Stock 1:1 08/08/00 M 1,000,000 Common Stock 1,000,000
------------------------------------------------------------------------------------------------------------------------------------
Series C Preferred Stock 1:1 08/08/00 M 750,741 Common Stock 740,741
------------------------------------------------------------------------------------------------------------------------------------
Series E Preferred Stock 1:1 08/08/00 M 1,602,564 Common Stock 1,602,564
------------------------------------------------------------------------------------------------------------------------------------
Common Stock Warrant $0.45 08/08/00 M 215,953 Immed. 08/08/00 Common Stock 215,953 (1)
(Right to Buy)
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
9. Number of 10. Ownership 11. Nature of
Derivative Form of Indirect
Securities Derivative Beneficial
Beneficially Security: Ownership
Owned at End Direct (D) (Instr. 4)
of Month or Indirect (I)
(Instr. 4) (Instr. 4)
--------------------------------------------------------------------------
-0- I
--------------------------------------------------------------------------
-0- I
--------------------------------------------------------------------------
-0- I
--------------------------------------------------------------------------
-0- I
--------------------------------------------------------------------------
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Explanation of Responses:
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ WILLIAM D. SAVOY Sept. 8, 2000
Note: File three copies of this Form, one of which must be manually signed. ------------------------------- ---------------
If space provided is insufficient, see Instruction 6 for procedure. **Signature of Reporting Person Date
Potential persons who are to respond to the collection of information Page 2 of 2
contained in this form are not required to respond unless the form SEC 1474 (7/96)
displays a currently valid OMB Number.
</TABLE>
(1) This warrant was exercised utilizing the net exercise feature.
(2) This warrant was issued in connection with the Company's Series C financing
which closed on April 1, 1999.
<PAGE> 3
JOINT FILER INFORMATION
Name: Vulcan Ventures Incorporated
Address: 110-110th Avenue N.E.
Ballevue, WA 98004
Designated Filer: Paul G. Allen
Issuer & Ticker Symbol: ROSETTA INPHARMATICS, INC. ("RSTA")
Date of Event
Requiring Statement: September 8, 2000
Signature: VULCAN VENTURES INCORPORATED
By: /s/ WILLIAM D. SAVOY
---------------------------------------
William D. Savoy, Vice President
